Archive
Everything published, newest first
November 2026
- 9 Nov · ConversationChristoph Lengauer: beyond one drug
- 8 Nov · ArticleHow to make a big decision: my three-step method, now as a free handbook
- 7 Nov · TributeMake it so: Sir Patrick Stewart and the calm way to lead
- 6 Nov · ConversationPhilipp Baaske: sell it before you build it
- 5 Nov · New serviceThe Focus Block: a new service level for leaders whose goal takes months
- 4 Nov · Article$358 million for the right to wait. What Boehringer’s China deal means for Europe’s biotech companies
- 4 Nov · ConversationAlex Zhavoronkov: can AI fix drug discovery?
- 3 Nov · ConversationAlasdair Milton: great science, missed patients
- 2 Nov · ArticleSixty billion dollars, zero approved drugs. Where does AI pay off in pharma?
- 1 Nov · Spark 20Alex Dang Spark 20: everyone agrees? Think again.
- 1 Nov · ConversationAlex Dang: conviction beats consensus
October 2026
- 31 Oct · Big QuestionsIs AI eating the whole market?
- 31 Oct · ConversationKarl Nehammer: why Europe fails to scale
- 31 Oct · Deep diveIntuitive Surgical: price for adoption in robotic surgery
- 31 Oct · New sectionDeep Dives: one company each week, read the way a board would
- 30 Oct · ConversationEric Ries: why good companies go bad after success
- 30 Oct · WebsiteThe new cslifescienceinvest.com is live